GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (SHSE:600332) » Definitions » Valuation Rank

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Valuation Rank


View and export this data going back to 2001. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Business Description

Traded in Other Exchanges
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.